Item type |
学術雑誌論文 / Journal Article_02(1) |
公開日 |
2025-05-23 |
タイトル |
|
|
タイトル |
A case of COVID-19-associated fulminant myocarditis successfully treated with mechanical circulatory support |
|
言語 |
en |
言語 |
|
|
言語 |
eng |
キーワード |
|
|
主題Scheme |
Other |
|
キーワード |
COVID‐19 |
キーワード |
|
|
主題Scheme |
Other |
|
キーワード |
ECMO |
キーワード |
|
|
主題Scheme |
Other |
|
キーワード |
fulminant myocarditis |
キーワード |
|
|
主題Scheme |
Other |
|
キーワード |
impella |
キーワード |
|
|
主題Scheme |
Other |
|
キーワード |
mechanical circulatory support (MCS) |
資源タイプ |
|
|
資源タイプ |
journal article |
アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
著者 |
Ryosuke, Asakura
Tatsuki, Kuroshima
Naohiro, Kokita
Motoi, Okada
|
bibliographic_information |
en : Clinical case reports
巻 10,
号 9,
p. e6185,
発行日 2022-09-02
|
ISSN |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2050-0904 |
DOI |
|
|
関連タイプ |
isIdenticalTo |
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1002/ccr3.6185 |
リンクURL |
|
|
内容記述タイプ |
Other |
|
内容記述 |
https://onlinelibrary.wiley.com/doi/10.1002/ccr3.6185 |
|
言語 |
en |
item_1716186501932 |
|
|
関連タイプ |
isIdenticalTo |
|
|
識別子タイプ |
PMID |
|
|
関連識別子 |
36093465 |
item_5_description_33 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
A 49-year-old man, who had not been vaccinated against COVID-19 visited the hospital for fever and cough, and a PCR test for COVID-19 was positive on the Day X. Initially, there was no decrease in oxygen saturation and the patient was under observation as a mild case without medication. Five days after the onset (Day X + 5), chest pain appeared. Electrocardiogram showed widespread ST-segment elevation, and blood tests showed high levels of troponin I. However, given that there was no stenotic lesion on coronary computed tomography, myocarditis was suspected, and he was transferred to our hospital on the Day X + 6. We started treatment with lemdesivir and dexamethasone. On the Day X + 7, the patient developed decreased left ventricular ejection fraction, hypotension, and hyperlactatemia. We decided that mechanical circulatory support was necessary and an Impella 5.0 was inserted under ventilator management. The patient was successfully weaned from the Impella 5.0 on the Day X + 17, was transferred to the general ward on the Day X + 24, continued rehabilitation, and was discharged home on the Day X + 39 with no heart failure symptoms. In this case, we performed daily bedside echocardiography and chose the Impella 5.0 instead of extra corporeal membrane oxygenation (ECMO) because there were no findings of severe pneumonia or right heart failure. The Impella 5.0 device was inserted via an axillary artery approach, given that it provides more assisted flow than the Impella CP inserted through the inguinal route. Furthermore, early rehabilitation was possible due to the lack of restriction of the lower body. |
|
言語 |
en |
注記 |
|
|
内容記述タイプ |
Other |
|
注記 |
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
|
言語 |
en |
出版タイプ |
|
|
出版タイプ |
VoR |
item_5_textarea_42 |
|
|
|
en |
|
|
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. |